Materials & Chemicals Market Research News

North America is expected to dominate global bioburden testing market with 57.6% market share followed by Europe and APAC by 2024 published by leading research firm

North America is expected to dominate global bioburden testing market with 57.6% market share followed by Europe and APAC by 2024 published by leading research firm

Global bioburden testing market is expected to reach USD 907.4 million by 2024 from USD 452.6 million in 2016, at a CAGR of 9.1% in the forecast period 2017 to 2024.

- Advertising -

Market Analysis:

Global bioburden testing market is expected to reach USD 907.4 million by 2024 from USD 452.6 million in 2016, at a CAGR of 9.1% in the forecast period 2017 to 2024. The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Request For Free Sample Report @: databridgemarketresearch.com/reque…en-testing-market

Global Bioburden Testing Market, By Test Type (Aerobic, Anaerobic, Fungi, Spore), By Product Type (Instruments (PCR, Automated Microbial Identification Systems, Microscopes, Others), Consumables (Kits & Strips, Reagents, Others), By Technology (Microbial Filter Method, Advanced Colorimetric Method, Plate Count Method, Rapid Testing), By Application (Raw Material Testing, In-Process Testing, Medical Device Testing, Pharmaceutical & Cosmetic Testing, Food and Beverage Testing), By End-User (Pharmaceutical, Biotechnology, Industrial, Food & Beverages), By Geography (North America, Europe, Asia-Pacific, South America and Middle East Asia) – Industry Trends and Forecast to 2024

Bioburden testing is the method of calculating the load of microorganisms, in or on a medical instrument, raw material, packaged goods among others. The results from bioburden testing are used to determine the sterilization methods to be used while processing the material.

- Advertising -

Every measurement requires a definitive unit to quantify it; in bioburden testing the unit is CFU (Colony forming Units) per gram or per square centimeter.

Market Segmentation:

The global bioburden testing market is segmented on the basis of test type, product type, technology, application, end-user, and geography.

On the basis of test type the bioburden testing market is segmented into aerobic, anaerobic, fungi and spore count. The global bioburden testing market segment is further categorized on the basis of product type into instruments and consumable.

The instrument market segment is sub-segment into automated microbial identification systems, PCR (polymerase chain reaction), microscopes. The consumables market segment is sub segmented into kits, reagents and other consumables.

Request for [email protected] databridgemarketresearch.com/toc/?…en-testing-market

On the basis of End User the market is segmented into Pharmaceutical, Biotechnology, Industrial, and Food & Beverage.

Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa. The geographical regions are further segmented into 24 major countries such as U.S.

Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others. In 2017, North America is expected to dominate the bioburden market with 57.6% market share followed by Europe and APAC.

However the APAC region is expected to grow at the highest CAGR of 17.4% in the forecast period 2017 to 2024

Competitive Analysis

The global bioburden testing market is highly fragmented with various companies operating in local regions. The major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market.

The report includes company share data for different geographies including Global, North America, Europe and APAC.

Top Companies:

The global bioburden testing market report contains an in-depth profiling of the key market players, along with the recent developments (innovative product launches, agreements, joint ventures, business and alliance) and strategies adopted by them to continue and build up their positions in the market. Some of the major players operating in this market are Charles, Pacific Bio labs, Inc., Sigma-Aldrich Corporation, SGS S.A., WuXi PharmaTech Inc., Becton, Dickinson and Company, Merck & Co., Inc., Charles River Laboratories International Inc., North American Science Associates, Inc. (NAMSA), Nelson Laboratories, Inc., Dynatec Labs, and ATS Labs, Inc. among others.

Access Full Report @ databridgemarketresearch.com/repor…n-testing-market/

News From

Data Bridge Market ResearchData Bridge Market Research
Category: Market Research Publishers and RetailersCompany profile: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...